351020-30-9

Upstream product

• 121904-08-3 3-(tert-butyldimethylsiloxy)-N-benzyl-propanaldimine 
• 100-46-9 benzylamine 
• 89922-82-7 3-(tert-butyldimethylsilanyloxy)propionaldehyde 
• 100516-54-9 (5S,6R)-4-(benzyloxycarbonyl)-5,6-diphenyl-2,3,5,6-tetrahydro-4H-1,4-oxazin-2-one 
• 145013-05-4 tert-butyl N-({[(tert-butoxy)carbonyl]amino}methanethioyl)carbamate 
• 351020-28-5 (3S,5S,6R)-3-[1-Benzylamino-3-(tert-butyl-dimethyl-silanyloxy)-propyl]-2-oxo-5,6-diphenyl-morpholine-4-carboxylic acid benzyl ester 

Downstream Products

• 351020-34-3 (3S,5S,6R)-3-{(R)-3-Benzyl-1-tert-butoxycarbonyl-2-[(Z)-tert-butoxycarbonylimino]-hexahydro-pyrimidin-4-yl}-2-oxo-5,6-diphenyl-morpholine-4-carboxylic acid benzyl ester 
• 351020-32-1 C₄₅H₅₂N₄O₉ 

Relevant academic research and scientific papers

The asymmetric synthesis of (2S,3R)-capreomycidine

An improved asymmetric synthesis of the guanidine-containing amino acid (2S,3R)-capreomycidine has been achieved in seven steps and 28% overall yield. The key synthetic step involved a Mannich-type reaction between a chiral glycine aluminum enolate and the benzyl-imine of 3-tert-butyldimethylsiloxy-propionaldehyde.